Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40 |
filingDate |
2000-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e815f68c110f4a6a463879cfdb61696e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_311bd5f060859af89b333ec84d15a825 |
publicationDate |
2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7118745-B1 |
titleOfInvention |
Engineering antibodies that bind irreversibly |
abstract |
The present invention provides a mutant antibody comprising a reactive site not present in the wild-type of the antibody and a complementarity-determining region that specifically binds to a metal chelate, wherein the reactive site is in a position proximate to or within the complementarity-determining region. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100861923-B1 |
priorityDate |
1999-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |